Template:Antibiotics Ludwigs Immunocompromised: Difference between revisions
Ostermayer (talk | contribs) (Marked this version for translation) |
(Convert to {{AntibioticDose}} for SMW antibiotic-disease linking) |
||
| Line 1: | Line 1: | ||
<noinclude><languages/></noinclude> | <noinclude><languages/></noinclude> | ||
<translate> | <translate> | ||
====Immunocompromised<ref>Spitalnic SJ, Sucov A. Ludwig's angina: case report and review. J Emerg Med. 1995;13:499-503</ref>==== | |||
====Immunocompromised<ref>Spitalnic SJ, Sucov A. Ludwig's angina: case report and review. J Emerg Med. 1995;13:499-503</ref>==== | |||
<!--T:2--> | <!--T:2--> | ||
* | *{{AntibioticDose|drug=Cefepime|dose=2 g IV q12 hrs|context=Immunocompromised}} + {{AntibioticDose|drug=Metronidazole|dose=500 mg IV q6 hrs|context=Immunocompromised}} OR | ||
* | *{{AntibioticDose|drug=Meropenem|dose=1 g IV q8 hrs|context=Immunocompromised}} OR | ||
* | *{{AntibioticDose|drug=Imipenem/Cilastatin|dose=500mg (20mg/kg) IV q6 hours|context=Immunocompromised}} | ||
* | *{{AntibioticDose|drug=Piperacillin/Tazobactam|dose=4.5g (80mg/kg) IV q6 hours|context=Immunocompromised}} | ||
*Add | *Add {{AntibioticDose|drug=Vancomycin|dose=15-20 mg/kg IV q8 hrs (max 2 g per dose)|context=Immunocompromised, MRSA}} if concern for MRSA risk factors | ||
</translate> | </translate> | ||
Revision as of 20:57, 19 March 2026
Immunocompromised[1]
- Cefepime 2 g IV q12 hrs + Metronidazole 500 mg IV q6 hrs OR
- Meropenem 1 g IV q8 hrs OR
- Imipenem/Cilastatin 500mg (20mg/kg) IV q6 hours
- Piperacillin/Tazobactam 4.5g (80mg/kg) IV q6 hours
- Add Vancomycin 15-20 mg/kg IV q8 hrs (max 2 g per dose) if concern for MRSA risk factors
- ↑ Spitalnic SJ, Sucov A. Ludwig's angina: case report and review. J Emerg Med. 1995;13:499-503